Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study

G A Eby, D R Davis, W W Halcomb, G A Eby, D R Davis, W W Halcomb

Abstract

As a possible treatment for common colds, we tested zinc gluconate lozenges in a double-blind, placebo-controlled, clinical trial. One 23-mg zinc lozenge or matched placebo was dissolved in the mouth every 2 wakeful h after an initial double dose. After 7 days, 86% of 37 zinc-treated subjects were asymptomatic, compared with only 46% of 28 placebo-treated subjects (P = 0.0005). Side effects or complaints were usually minor and consisted mainly of objectionable taste and mouth irritation. Zinc lozenges shortened the average duration of common colds by about 7 days.

References

    1. Lancet. 1967 Jan 21;1(7482):121-4
    1. Nature. 1974 Apr 12;248(449):588-90
    1. J Virol. 1974 Aug;14(2):282-91
    1. J Virol. 1976 Apr;18(1):298-306
    1. Proc Soc Exp Biol Med. 1976 Jul;152(3):455-8
    1. Arch Virol. 1976;51(3):169-89
    1. Br J Clin Pharmacol. 1976 Oct;3(5):869-78
    1. Virology. 1978 Feb;84(2):551-4
    1. Vrach Delo. 1977 Dec;(12):57-61
    1. Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(6):727-32
    1. Acta Derm Venereol. 1980;60(2):175-77
    1. J Med. 1980;11(2-3):143-67
    1. Am J Clin Nutr. 1981 Jan;34(1):88-93
    1. Br J Dermatol. 1981 Feb;104(2):191-4
    1. Am J Med. 1981 May;70(5):1001-4
    1. J Clin Immunol. 1981 Jan;1(1):73-9

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren